XML 45 R33.htm IDEA: XBRL DOCUMENT v3.21.2
FINANCIAL INSTRUMENTS (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of carrying amount and fair value of the long-term debt
At September 30, 2021, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands):
Carrying ValueFair Value Measurements Using
Level 1Level 2Level 3
Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:
Financial Assets:
   Notes receivable$4,164 $— $— $4,164 
Financial Liabilities:
   Acquisition-related contingent consideration$16,199 $— $— $16,199 
Financial Liabilities Measured at Amortized Cost:
   2.375% convertible senior notes due 2022 (1)
$155,751 $— $166,000 $— 
   0.750% convertible senior notes due 2025 (1)
$326,146 $— $437,216 $— 
(1) The closing price of the Company’s common stock as reported on the Nasdaq Global Select Market was $56.00 per share on September 30, 2021, compared to a conversion price of $66.89 per share for the 2022 Notes and $71.78 per share for the 2025 Notes. The maximum conversion premium that could have been due on the 2022 Notes and 2025 Notes at September 30, 2021 was approximately 2.4 million and 5.6 million shares of the Company’s common stock, respectively. These figures assume no increases in the conversion rate for certain corporate events.
Schedule of key assumptions used in the valuation of contingent consideration
The following table includes the key assumptions used in the valuation of the Company’s contingent consideration:
AssumptionRanges Utilized as of September 30, 2021
Discount rates
3.49% to 3.81%
Probabilities of payment for regulatory milestones
2% to 100%
Projected years of payment for regulatory and commercial milestones2021 to 2023
Schedule of change in contingent consideration recorded at fair value using Level 3 measurements The change in the Company’s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):
Contingent Consideration
Fair Value
Balance at December 31, 2020$28,346 
   Fair value adjustments and accretion(2,147)
   Payments made(7,000)
   Offset indemnification claims(3,000)
Balance at September 30, 2021$16,199 
Schedule of short-term investments
The following summarizes the Company’s investments at September 30, 2021 and December 31, 2020 (in thousands):
September 30, 2021 InvestmentsCostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
(Level 2)
Short-term:
   Asset-backed securities$17,615 $$(2)$17,616 
   Commercial paper423,302 82 — 423,384 
   Corporate bonds32,612 — (7)32,605 
   U.S. Government bonds86,194 24 (1)86,217 
          Total$559,723 $109 $(10)$559,822 

December 31, 2020 InvestmentsCostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
(Level 2)
Short-term:
   Asset-backed securities$34,918 $98 $— $35,016 
   Commercial paper221,494 36 (18)221,512 
   Corporate bonds120,375 179 (11)120,543 
   U.S. Government bonds44,629 (2)44,634 
      Subtotal421,416 320 (31)421,705 
Long-term:
   U.S. Government bonds95,429 30 — 95,459 
      Subtotal95,429 30 — 95,459 
          Total$516,845 $350 $(31)$517,164